Ivana Magovcevic-Liebisch
Insider
First SEC filing: July 21, 2021 · Latest: July 21, 2021
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs the latest weekly close (updated to the current quote in your browser when available), split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 2, 2026 | QTRX | M | 4,224 | · | · | 15,883 Direct | +36.23% | Acquired | |
| Oct. 2, 2026 | QTRX | M | 4,224 | · | · | 4,352 Direct | -49.25% | Disposed | |
| June 17, 2026 | ACRV | A | 20,275 | · | · | 20,275 Direct | · | Acquired | |
| May 18, 2026 | ACRV | A | 9,366 | · | · | 9,366 Direct | · | Acquired | |
| Jan. 2, 2026 | QTRX | A | 23,372 | · | · | 43,607 Direct | +115.50% | Acquired | |
| June 13, 2025 | ACRV | A | 20,275 | · | · | 20,275 Direct | · | Acquired | |
| Jan. 2, 2025 | QTRX | A | 7,435 | · | · | 20,235 Direct | +58.09% | Acquired | |
| Jan. 2, 2025 | QTRX | A | 15,821 | · | · | 15,821 Direct | · | Acquired | |
| Oct. 2, 2024 | QTRX | A | 12,800 | · | · | 12,800 Direct | · | Acquired | |
| Oct. 2, 2024 | QTRX | A | 27,689 | · | · | 27,689 Direct | · | Acquired | |
| Feb. 8, 2024 | ACRV | A | 32,500 | · | · | 32,500 Direct | · | Acquired | |
| June 22, 2023 | SYRE | A | 1,950,000 | · | · | 1,950,000 Direct | · | Acquired | |
| June 8, 2022 | ABSI | A | 28,700 | · | · | 28,700 Direct | · | Acquired | |
| June 7, 2022 | SYRE | A | 43,000 | · | · | 43,000 Direct | · | Acquired | |
| June 8, 2021 | SYRE | A | 40,000 | · | · | 40,000 Direct | · | Acquired | |
| June 8, 2020 | SYRE | A | 28,100 | · | · | 28,100 Direct | · | Acquired | |
| June 7, 2019 | SYRE | A | 12,400 | · | · | 12,400 Direct | · | Acquired | |
| March 22, 2018 | SYRE | A | 36,800 | · | · | 36,800 Direct | · | Acquired |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 2, 2026 | QTRX | Restricted Stock Unit | Common Stock | $0.00 | · | 4,224 | Disposed |
| June 17, 2026 | ACRV | Stock Option (Right to Buy) | Common Stock | $1.52 | June 16, 2036 | 20,275 | Acquired |
| June 13, 2025 | ACRV | Stock Option (Right to Buy) | Common Stock | $1.20 | June 12, 2035 | 20,275 | Acquired |
| Jan. 2, 2025 | QTRX | Stock Option (Right to Buy) | Common Stock | $10.76 | Jan. 2, 2035 | 15,821 | Acquired |
| Oct. 2, 2024 | QTRX | Common Stock | Common Stock | $12.50 | Oct. 2, 2034 | 27,689 | Acquired |
| Feb. 8, 2024 | ACRV | Stock Option (Right to Buy) | Common Stock | $3.54 | Feb. 7, 2034 | 32,500 | Acquired |
| June 22, 2023 | SYRE | Stock Option (right to buy) | Common Stock | $0.30 | June 22, 2033 | 1,950,000 | Acquired |
| June 8, 2022 | ABSI | Stock Option (right to buy) | Common Stock | $3.39 | June 7, 2032 | 28,700 | Acquired |
| June 7, 2022 | SYRE | Director Stock Option (right to buy) | Common Stock | $0.73 | June 6, 2032 | 43,000 | Acquired |
| June 8, 2021 | SYRE | Director Stock Option (right to buy) | Common Stock | $6.80 | June 7, 2031 | 40,000 | Acquired |
| June 8, 2020 | SYRE | Director Stock Option (right to buy) | Common Stock | $8.89 | June 7, 2030 | 28,100 | Acquired |
| June 7, 2019 | SYRE | Director Stock Option (right to buy) | Common Stock | $6.33 | June 6, 2029 | 12,400 | Acquired |
| March 22, 2018 | SYRE | Director Stock Option (right to buy) | Common Stock | $10.50 | March 21, 2028 | 36,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.